Log In
BCIQ
Print this Print this
 

Priorix-Tetra (GSK209762)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLive attenuated vaccine for measles, mumps, rubella and varicella prophylaxis
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationViral infection
Indication DetailsVaccinate against measles, mumps, rubella and varicella
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$65.6M

$65.6M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/12/2009

$65.6M

$65.6M

0

Get a free BioCentury trial today